CompletedPhase 3NCT06497491
An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease
Studying Adult-onset Still disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AO GENERIUM
- Principal Investigator
- Oksana A. Markova, MDJSC GENERIUM
- Intervention
- GNR-086(biological)
- Enrollment
- 118 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2023 – 2025
Study locations (17)
- State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Chelyabinsk Oblast, Russia
- Limited Liability Company "Medical Center "Revma-Med", Kemerovo, Kemerovo Oblast, Russia
- Limited Liability Company "OLLA-MED", Moscow, Moscow, Russia
- Federal State Budgetary Institution "Research Institute of Rheumatology named after V.A. Nasonova", Moscow, Moscow, Russia
- State budgetary healthcare institution of the city of Moscow "City Clinical Hospital No. 52 of the Moscow Health Department" (GBUZ "City Clinical Hospital No. 52 DZM"), Moscow, Moscow, Russia
- Federal State Autonomous Educational Institution of Russian National Research Medical University named after. N. I. Pirogova, Moscow, Moscow, Russia
- Federal State Autonomous Educational Institution of Russian National Research Medical University named after. N.I. Pirogov Ministry of Health of Russia Separate structural unit "Russian Gerontological Scientific and Clinical Center", Moscow, Moscow, Russia
- Limited Liability Company "Medical Center "Healthy Family", Novosibirsk, Novosibirsk Oblast, Russia
- Federal State Budgetary Educational Institution of Higher Education Orenburg State Medical University of the Ministry of Health of Russia, Orenburg, Orenburg Oblast, Russia
- Limited Liability Company "Medical Technologies" LLC "Medical Technologies", Saint Petersburg, Sankt-Peterburg, Russia
- Limited Liability Company "Ex Seven Clinical Research", Saint Petersburg, Sankt-Peterburg, Russia
- Limited Liability Company "Interleukin", Saint Petersburg, Sankt-Peterburg, Russia
- State Budgetary Healthcare Institution Leningrad area Clinical Hospital, Saint Petersburg, Sankt-Peterburg, Russia
- Private foundation "RZD-Medicine" Smolensk", Smolensk, Smolensk Oblast, Russia
- Limited Liability Company "BioMed", Vladimir, Vladimirskaya Oblast’, Russia
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06497491 on ClinicalTrials.govOther trials for Adult-onset Still disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07203001A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseNovartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE3NCT05814159A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)Swedish Orphan Biovitrum
- RECRUITINGNCT04402086Rheumatology Patient Registry and BiorepositoryYale University
- RECRUITINGNCT03510442Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- RECRUITINGNCT05927454Acostill ( RaDiCo Cohort) (RaDiCo Acostill)Institut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNCT02143986Glycosylated Ferritin in Macrophagic Activation SyndromesBrugmann University Hospital